Net Cash Provided by (Used in) Operating Activities |
-26.9K |
USD |
+67.8% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
16.3K |
USD |
-76.5% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
25M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
3.47M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-10.5K |
USD |
-155% |
Q1 2025 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-81.6K |
USD |
-379% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
22.9M |
USD |
0% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Current State and Local Tax Expense (Benefit) |
29K |
USD |
+199% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
1.35M |
USD |
+65.7% |
Q4 2023 |
FY 2024 |
Share-based Payment Arrangement, Expense |
82.4K |
USD |
-62.6% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |